MORGANTOWN — Hope Gas will be the first new tenant in WVU Innovation Corp.'s Chestnut Ridge Road facility — the former Mylan pharmaceuticals plant. The Innovation Corp. made the announcement Wednesday afternoon, noting at the same time that Hope Gas was acquired Wednesday by ...
WVU TODAY The Art Museum of West Virginia University announced support from Art Bridges to develop and tour a major exhibition of the work of Blanche Lazzell, one of the most progressive American artists of the first half of the 20th century. A West Virginia native, Lazzell created some ...
The summer Nature Connection Series continues this week at the WVU Core Arboretum’s woodland amphitheater. The talk begins at 6 p.m. today. The series runs each Tuesday evening through the summer. This week’s speaker is David Scofield, director of Meadowcroft Rockshelter. His talk ...
MORGANTOWN – Some WVU law professors are concerned that proposed changes to a Board of Governors rule will create unconstitutional restrictions on their ability to represent plaintiffs or testify in lawsuits filed against the state. They think the changes stem from political pressure from ...
WVU TODAY Maintaining a sharp focus on the unique needs of rural, underrepresented West Virginia University students, the Office of Student Success welcomes its first cohort of Mountain Scholars this fall. The Mountain Scholars Program is designed to create a culture of support for incoming first-year students from rural areas of West Virginia as they work toward academic success while also preparing them for jobs in the Mountain State. “The program will help our in-state students transition to college life, build a sense of community and belonging and develop a deeper ...
WVU MEDICINE The West Virginia University Rockefeller Neuroscience Institute (RNI) launched afirst-in-the-world clinical trial pairing focused ultrasound treatment with Alzheimer’s antibody drug therapy to a targeted area of the brain, unlocking new potential for the treatment of the disease. The first participant, a 77-year-old man from West Virginia, received the combination of Aduhelm (generic: aducanumab), a monoclonal antibody treatment that targets beta amyloid plaques as part of the FDA-approved trial. With the antibody in the patient’s bloodstream, researchers aimed ...
